Clinical Trials
4 trialsNCT01330446 2024-02-14
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00536172 2023-09-21
PROTECT
University of Nebraska
Phase 4 Completed
NCT02055963 2022-10-20
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01427205 2013-04-05
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 2 Withdrawn